GLP-1s in Dermatology

In recent years, GLP-1 receptor agonists (such as semaglutide and tirzepatide) have gained attention not only for their role in weight management and diabetes care but also for their potential impact on skin health. At OneSkin Dermatology in Chambersburg, PA, we stay on top of emerging research to understand how these medications may support patients beyond metabolic health.

Weight and Skin Health

Excess weight can contribute to common dermatologic concerns such as skin fold irritation, acanthosis nigricans, and delayed wound healing. By supporting weight reduction, GLP-1s may indirectly improve these issues, helping patients feel more comfortable in their skin.

Inflammation and Skin Diseases

GLP-1s have been shown to influence inflammatory pathways in the body. Since many skin conditions are inflammatory in nature, researchers are investigating how GLP-1s may provide benefit:

• Psoriasis – Early studies suggest GLP-1 therapy may improve psoriasis severity by reducing systemic inflammation and modifying immune responses.
• Hidradenitis Suppurativa (HS) – Because obesity and inflammation play a role in HS, weight reduction and anti-inflammatory effects from GLP-1s could lessen flare frequency and severity.
• Other Inflammatory Skin Conditions – Conditions such as atopic dermatitis and acne may also be indirectly influenced by the overall metabolic and inflammatory improvements GLP-1s provide.

Looking Ahead

While more research is needed, the connection between GLP-1s, inflammation, and skin health is an exciting area of dermatology. At OneSkin Dermatology in Chambersburg, PA, we are committed to educating our patients on cutting-edge therapies and how whole-body health connects with skin wellness.